Atlas Trials

Bronchiolitis Obliterans (BO)

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Bronchiolitis Obliterans (BO)

RecordFirmDate
Ruxolitinib for Early Lung Dysfunction After Hematopoietic Stem Cell Transplant (NCT04908735)Children's Hospital Medical Center, Cincinnati2021-11-12
Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation (NCT03805477)University Hospital, Basel, Switzerland2019-03-20

Track Bronchiolitis Obliterans (BO) automatically

Every clearance here is in the API, with alerts when new ones post.